Brochure Nitrosamine in Pharma GC Ms 5994 2979en Agilent
Brochure Nitrosamine in Pharma GC Ms 5994 2979en Agilent
Brochure Nitrosamine in Pharma GC Ms 5994 2979en Agilent
in Pharmaceuticals
Using Single Quadrupole GC/MS or Triple Quadrupole GC/MS
Consumables workflow ordering guide
R1
R2
N
N R 1 R
2
O N
2 N
R 1 R
2 O
N R 1 R
N N
O N
Mutagenic impurities in APIs and drug products pose a significant risk to health and safety—
even in small quantities—and thus are a major concern for drug makers. Mutagenic impurities
can damage DNA, leading to mutations and potentially cancer. Efforts to address and control
the presence of trace levels of mutagenic impurities is of special concern to global regulators.
As a result, the U.S. FDA and other regulatory agencies have taken steps to address the issue
of mutagenic impurities in pharmaceuticals1. Detection and quantification of these trace
nitrosamines in APIs and drug products can be challenging, necessitating the use of advanced
and sensitive tools to meet regulatory requirements.
Sartan drugs are angiotensin II receptor blockers (ARBs), used to treat high blood
pressure and congestive heart failure (1). Metformin is an oral diabetes drug used
to control blood sugar levels. Ranitidine products treat heartburn and acid reflux.
All have recently been recalled by the FDA due to the presence of high levels of
nitrosamine impurities:
– N-nitrosodimethylamine (NDMA)
– N-nitrosodiethylamine (NDEA)
– N-nitrosodiisopropylamine (NDIPA)
– N-nitrosoethylisopropylamine (NEIPA)
– N-nitrosodibutylamine (NDBA)
These impurities are classified as probable human carcinogens, may be The Agilent 8890 GC/7693 LS/ 7010B GC/TQ
2
¹U.S. FDA: www.fda.gov/media/131868/download Council of Europe: www.edqm.eu/en/news/omcls-release-three-methods-determination-ndma-sartans
Health Canada: healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2020/72963a-eng.php Taiwan FDA: www.fda.gov.tw/ENG/siteList.aspx?sid=10360
FDA Method 1: GC/MS headspace method to detect NDMA and NDEA
This method (3) detects the presence of two impurities, NDMA and NDEA, using
GC/MS headspace analysis.
Figure 1. Generated chromatogram in select ion mode of a 1 μg standard mix of NDMA and NDEA
in NMP. NDMA retention time is 5.80 minutes, and NDEA is 7.25 minutes.
Method Parameters
The Agilent 8890/5977 GC/MSD equipped with a 7697A headspace sampler is
recommended for this analysis (4). Method parameters are shown below.
Flow 1 mL/min
3
FDA Method 1 Ordering Information
Click the MyList* links in the header below to add items to your “Favorite
Products” list at the Agilent online store. Then, enter the quantities for the
products you need. Your list will remain under “Favorite Products” for your use
with future orders.
Click MyList to download all items in this table to your Favorite Products list
Product Description Part Number
Nitrosamine Standards
Nitrosamine - GC Column
DB-1701 30 m x 0.25 mm, 1.0 µm 122-0733
Inlet liner, Ultra Inert, split, low pressure drop, glass wool 5190-2295
Nitrosamines-Inlet Supplies
Vial, headspace, certified, crimp, clear, flat bottom, 20 mL, 100/pk 5182-0837
Gas Filters
Gas Clean Carrier Gas Kit for 8890 and 8860 CP179880
Nitrosamines-MS Supplies
EI Filament (for 7000A/B/C/D, 5977B Inert Plus, 5977A Extractor, Inert or G7005-60061
Stainless steel and 5975 systems)
1.
Ultra Inert supplies provide excellent surface inertness through the entire flow path, prevent analyte catalytic breakdown,
response loss and peak shape distortion and thus support reliable qualitative and quantitative analysis for sensitive analysis.
GC column inertness is critical as columns contribute toward the largest surface area within the flow path.
* First time using “MyList”? You will be asked to enter your email address for account verification. If you have an existing Agilent
account, you will be able to log in. If you don’t have a registered Agilent account, you will need to register for one. This feature
is valid only in regions that are e-commerce enabled. All items can also be ordered through your regular sales and distributor
channels.
4
FDA Method 2: GC/MS headspace method to detect NDMA, NDEA,
NEIPA and NDIPA
Method 2 (5) is a later version of the FDA method and uses a single quadrupole
GC/MS with headspace-based injection to detect four impurities. The method
was validated using an Agilent 7890B GC System with an Agilent 5977A MSD and
an Agilent 7697A Headspace Sampler.
Table 2. The limits of detection (LOD) and limits of quantitation (LOQ) for this method.
Impurity Drug Substance Drug Substance LOD Drug Product LOQ Drug Product LOD
LOQ (ppm) (ppm) (ppm) (ppm)
5
FDA Method 2 Ordering Information
Click the MyList* links in the header below to add items to your “Favorite
Products” list at the Agilent online store. Then, enter the quantities for the
products you need. Your list will remain under “Favorite Products” for your use
with future orders.
Click MyList to download all items in this table to your Favorite Products list
Product Description Part Number
Nitrosamine Standards
Nitrosamine - GC Column
DB-WAX 30 m x 0.25 mm, 0.5 µm 122-7033
Inlet liner, Ultra Inert¹, split, low pressure drop, glass wool 5190-2295
Nitrosamines-Inlet Supplies
Vial, headspace, certified, crimp, clear, flat bottom, 20 mL, 100/pk 5182-0837
Gas Filters
Gas Clean Carrier Gas Kit for 8890 and 8860 CP179880
Nitrosamines-MS Supplies
EI Filament (for 7000A/B/C/D, 5977B Inert Plus, 5977A Extractor, Inert or G7005-60061
Stainless steel and 5975 systems)
6
FDA Method 3: GC/TQ method utilizing liquid injection to
simultaneously quantify NDMA, NDEA, NEIPA, NDIPA and NDBA
This method (6) is also a later version of the first FDA method. It is a liquid
injection based method using triple quadrupole GC/TQ and analyzes for five
impurities. Single quadrupole MS (methods 1 & 2) often gives ambiguous
results and is less sensitive. GC/TQ methods are more sensitive and give better
specificity. A headspace transfer line accessory allows both headspace and liquid
injection capability on the same inlet, without changing the configuration.
Drug substance LOD/LOQ calculations for this method were based on 500 mg
of Valsartan API. Increasing the amount weighed out and extracted will lower
the reported LOQ. Drug product LOD/LOQ calculations were based on one tablet
containing 30 mg of Valsartan API.
Table 3. The limits of detection (LOD) and limits of quantitation (LOQ) for the FDA method 3.
×104 +EI MRM CID@10.0 (158.0 -> 99.0) 2,5ng_mL_001.D
Impurity Drug Substance Drug Substance Drug Product LOQ Drug Product LOD
1.8 12 23 34 45
1.7
LOQ (ppm) LOD (ppm) (ppm) (ppm) 1.6
1.5
NEIPA
1.4
NDMA 0.008 0.005 0.013 0.008 1.3
1.2
NDEA 0.005 0.001 0.008 0.002 1.1
1.0
Counts
NEIPA 0.005 0.001 0.008 0.002 0.9
0.8 NDMA
NDIPA 0.005 0.001 0.008 0.002 0.7
0.6
NDEA
NDBA 0.025 0.010 0.040 0.016 0.5
NDIPA
0.4
0.3 NDBA
Agilent offers a comprehensive solution (7) for the determination and estimation
0.2
0.1
metformin (8) and sartan (9) drug products and drug substances at trace levels
Acquisition time (min)
using an Agilent 7890B or 8890 GC coupled to an Agilent 7010B triple quadrupole Figure 3. Extracted MRM chromatogram
GC/MS system. An Agilent 7010B triple quadrupole GC/MS, equipped with a (quant transition) of lowest calibration
high efficiency source, can achieve LOQs that are 2–20 times lower than those standard at 2.5 ng/mL mix of five impurities in
dichloromethane (Agilent 7890B GC).
required by current regulations.
Method parameters
Total Run Time 12.33 min Quenching Gas Flow Helium at 4 mL/min
Click MyList to download all items in this table to your Favorite Products list
Nitrosamine Standards
Nitrosamine - GC Column
Single taper splitless Inlet liner 900 µL with deactivated wool 5062-3587
Single taper, splitless, Inlet liner 900 µL with glass wool Ultra Inert¹ (1/pk) 5190-2293
Single taper, splitless, Inlet liner 900 µL with glass wool Ultra Inert¹ (5/pk) 5190-3163
Single taper, splitless, Inlet liner 900 µL with glass wool Ultra Inert¹ (25/pk) 5190-3167
Single taper, splitless, Inlet liner 900 µL with glass wool Ultra Inert¹ (100/pk) 5190-3171
Inlet liner O-ring, non-stick fluorocarbon, certified, 100/pk 5190-2269
Nitrosamines-Inlet Supplies
MS analyzed vial kit, 2 mL clear screw top,write-on spots, blue caps, PTFE/ 5190-2278
silicone septa, 100/pk
Vial, screw top, amber, write-on spot, certified, 2 mL, 100/pk 5182-0716
Vial, screw top, amber, write-on spot, deactivated (silanized), certified, 2 5183-2072
mL, 100/pk
Screw cap, blue PTFE/red silicone septa, 100/pk 5182-0717
8
Gas Filters
Gas Clean Carrier Gas Kit for 8890 and 8860 CP179880
Nitrosamines-MS Supplies
EI Filament (for 7000A/B/C/D, 5977B Inert Plus, 5977A Extractor, Inert or G7005-60061
Stainless steel and 5975 systems)
9
Agilent CrossLab: Real insight, real outcomes
CrossLab goes beyond instrumentation to bring you services, consumables,
and lab-wide resource management. So your lab can improve efficiency,
optimize operations, increase instrument uptime, develop user skill, and more.
RA44239.5775